Vimarsana
Biggest News Aggregation in the World

Page 41 - Michael Orourke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Orourke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Orourke Today - Breaking & Trending Today

GLOBAL MARKETS-Wall St stocks fall, bond yields rise as China drops quarantine rule - Vimarsana News

GLOBAL MARKETS-Wall St stocks fall, bond yields rise as China drops quarantine rule

Oil futures, after hitting a three-week high earlier in the day, were a mixed bag at settlement with restarts at some U.S. energy plants shut by winter storms offseting hopes for a recovery in demand after China's latest easing restrictions. The rise in Treasury yields put pressure on growth stocks including the rate-sensitive technology sector, according to Michael O’Rourke, chief market strategist at JonesTrading in Stamford, Connecticut.

GLOBAL MARKETS-Wall St stocks fall, oil rises as China drops quarantine rule - Vimarsana News

GLOBAL MARKETS-Wall St stocks fall, oil rises as China drops quarantine rule

U.S. Treasury yields rose after data showed the advance goods trade deficit for November narrowed to $83.35 billion from the prior month's $98.8 billion, while a separate report pointed to continued struggles for the housing market as home prices fell under rising mortgage rates. While oil pared gains as some U.S. energy facilities shut by winter storms began to restart, the commodity had earlier hit a three-week high as China's latest easing of COVID restrictions spurred hopes of a recovery in demand.

Break-Out QUB Firm Secures £10m Research Investment | Northern Ireland News, 05/12/2022 - Vimarsana News

Break-Out QUB Firm Secures £10m Research Investment | Northern Ireland News, 05/12/2022

Re-Vana Therapeutics To Research Sight-Threatening Eye Disease

Source: 4ni.co.uk
Re-Vana Therapeutics raises $11.9m to boost eye disease treatment - Vimarsana News

Re-Vana Therapeutics raises $11.9m to boost eye disease treatment

Re-Vana Therapeutics is developing technology that can provide sustained drug delivery for up to six months for people with eye diseases.

Belfast-based Re-Vana Therapeutics raises $11.9m - Vimarsana News

Belfast-based Re-Vana Therapeutics raises $11.9m

Queen’s spin-out is developing therapeutics for the treatment of vision-threatening ocular diseases